Drug Developmental Research Laboratories, Shionogi & Co., Ltd., 3-1-1 Futaba-cho, Toyonaka, Osaka 561-0825, Japan.
Toxicol Appl Pharmacol. 2011 Sep 15;255(3):297-306. doi: 10.1016/j.taap.2011.07.001. Epub 2011 Jul 19.
The present study was performed to develop a robust gene-based prediction model for early assessment of potential hepatocarcinogenicity of chemicals in rats by using our toxicogenomics database, TG-GATEs (Genomics-Assisted Toxicity Evaluation System developed by the Toxicogenomics Project in Japan). The positive training set consisted of high- or middle-dose groups that received 6 different non-genotoxic hepatocarcinogens during a 28-day period. The negative training set consisted of high- or middle-dose groups of 54 non-carcinogens. Support vector machine combined with wrapper-type gene selection algorithms was used for modeling. Consequently, our best classifier yielded prediction accuracies for hepatocarcinogenicity of 99% sensitivity and 97% specificity in the training data set, and false positive prediction was almost completely eliminated. Pathway analysis of feature genes revealed that the mitogen-activated protein kinase p38- and phosphatidylinositol-3-kinase-centered interactome and the v-myc myelocytomatosis viral oncogene homolog-centered interactome were the 2 most significant networks. The usefulness and robustness of our predictor were further confirmed in an independent validation data set obtained from the public database. Interestingly, similar positive predictions were obtained in several genotoxic hepatocarcinogens as well as non-genotoxic hepatocarcinogens. These results indicate that the expression profiles of our newly selected candidate biomarker genes might be common characteristics in the early stage of carcinogenesis for both genotoxic and non-genotoxic carcinogens in the rat liver. Our toxicogenomic model might be useful for the prospective screening of hepatocarcinogenicity of compounds and prioritization of compounds for carcinogenicity testing.
本研究旨在利用我们的毒理基因组学数据库 TG-GATEs(由日本毒理基因组学计划开发的基因组辅助毒性评估系统),开发一种用于大鼠化学物潜在肝致癌性早期评估的稳健基因预测模型。阳性训练集由高剂量或中剂量组组成,这些组在 28 天内接受了 6 种不同的非遗传毒性肝致癌剂。阴性训练集由高剂量或中剂量组的 54 种非致癌剂组成。支持向量机结合包装型基因选择算法用于建模。结果,我们的最佳分类器在训练数据集中对肝致癌性的预测准确率为 99%的敏感性和 97%的特异性,并且几乎完全消除了假阳性预测。特征基因的通路分析表明,丝裂原激活蛋白激酶 p38 和磷脂酰肌醇-3-激酶为中心的相互作用网络和 v-myc 髓细胞瘤病毒癌基因同源物为中心的相互作用网络是两个最重要的网络。我们的预测器在来自公共数据库的独立验证数据集中的有效性和稳健性得到了进一步证实。有趣的是,在几种遗传毒性肝致癌剂和非遗传毒性肝致癌剂中也得到了类似的阳性预测。这些结果表明,我们新选择的候选生物标志物基因的表达谱可能是遗传毒性和非遗传毒性致癌剂在大鼠肝脏致癌作用早期的共同特征。我们的毒理基因组学模型可能有助于化合物的肝致癌性的前瞻性筛选和致癌性测试化合物的优先级排序。